American Medical Association Urges Congress to Avert Devastating Medicare Cuts

Translate to Spanish or other 102 languages!

By introducing a bipartisan agreement today, Congress took a decisive step toward preserving the viability of physician practices and maintaining access to care. Image source:  ama-assn.org
By introducing a bipartisan agreement today, Congress took a decisive step toward preserving the viability of physician practices and maintaining access to care. Image source: ama-assn.org

Mega Doctor News

- Advertisement -

Statement attributable to:
Gerald E. Harmon, M.D.
President, American Medical Association   

“By introducing a bipartisan agreement today, Congress took a decisive step toward preserving the viability of physician practices and maintaining access to care.

“This agreement would postpone substantial reductions in Medicare payment for physician services, providing valuable time for identifying the fundamental system reforms needed to stabilize and support innovation in this critically important program.

- Advertisement -

“We urge the House and Senate to support this bipartisan proposal and join together again in the new year to develop long-term solutions to address the flaws in the Medicare payment system.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 
- Advertisement -